|
CARDIOVASCULAR
|
Volume 2, 1997, No 2 |
Abstract:
A new generation of perfluorochemical (PFC) emulsions are
entering clinical evaluation for use as erythrocyte substitutes
during cardiac operations. PFC emulsions used in conjunction with
a high PO2 substantially increase the dissolved oxygen (O2)
content of blood. This additional O2, which is readily available
for diffusion into tissue, increases the capacity of the pump
oxygenator to deliver O2 to the body during cardiopulmonary
bypass (CPB). The ability of PFC emulsions to dissolve O2 in the
plasma fraction of blood has important implications for the
conduct of cardiac operations.
Keywords:
Perfluorochemical, blood, oxygen, myocardium, cardiopulmonary
bypass
Address for Correspondence:
Reference:
(CVE. 1997; 2 (2): 113-119)
[Pabst Science Publishers] [CVE Homepage] [Contents] [Editorials] [Masthead] [Search] [Orders]
![]()
PABST SCIENCE PUBLISHERS
Lengerich, Berlin, Düsseldorf,
Leipzig, Riga, Scottsdale AZ (USA),
Wien, Zagreb